8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Apr 13, 2026 · 2mo ago · Accession 0001628280-26-024831
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Spyre Therapeutics, Inc.
- Ticker
- SYRE
- CIK
- 1636282
- Form type
- 8-K
- Filing date
- Apr 13, 2026
- Report date
- Apr 13, 2026
- Document
- syre-20260413.htm
- Size
- 4.6 MB